Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Update: Investigations Under the CARES Act Ramp Up Even as Oversight Roles Remain Vacant
U.S. Paycheck Protection Program Loan Recipients: Risks of Qui Tam Actions Under the False Claims Act
Mitigating Bribery and FCPA Risks in the Time of COVID-19
The PPP Litigation Wave Is Coming: Anticipated “Qui Tam” Lawsuits Under the False Claims Act
The Value of the Whistleblower Program
Former U.S. Marine Corps Subcontractor Pleads Guilty to Obstruction of Justice
Purchasing a Rolls-Royce Is Not a Permissible Use of PPP Funds
12 Steps for Reducing CARES Act Enforcement Risks
Fluor Receives DOJ Subpoena Related to Prior-Period Reporting
Human Trafficking: Recognizing the Signs
Consumer Lender Sets Aside $21.7 Million For Bribery Settlement
Cancer Treatment Center Agrees to DPA and $100 Million Penalty for Criminal Antitrust Violations in Florida Market
Top 10 International Anti-Corruption Developments for April 2020
Walmart Ex-Compliance Officer Sues Over FCPA Case
False Claims Act Exposure for Beneficiaries of the Public Health and Social Services Emergency Relief Fund: Mitigating Risks of Ambiguous Terms & Conditions
Clinical Laboratory to Pay $43 Million to Resolve FCA Liability for Medically Unnecessary Tests; Settlement Demonstrates Importance of Addressing Employee Compliance Concerns
World Bank Debars China Power Company for Fraud
California False Claims Expansion Bill Preparing to Advance
Qui Tam Complaint Against Pharmacy Dismissed for Lack of Particularity
Keep reading
